Chronic Hepatitis

Top Story

Dicerna doses first patient in trial of RNA inhibitor for chronic HBV

May 17, 2019
In the Journals

EGALITE study confirms efficacy of elbasvir/grazoprevir for patients with HCV, mild fibrosis

May 16, 2019
Results from the EGALITE study showed that 12 weeks of elbasvir/grazoprevir was a highly effective regimen for treatment-naive Asian patients with hepatitis C virus…

Alcohol-related hepatitis therapy lowers Lille score, bilirubin, MELD

May 13, 2019
Durect Corporation announced preliminary data from an ongoing phase 2a trial of DUR-928 for alcohol-related hepatitis, according to a press release. To date, 10 patients…

HepaStem therapy moves into phase 2 trials for NASH, ACLF

May 10, 2019
Promethera Biosciences dosed the first patient in a phase 2a clinical study of HepaStem for patients with late stage nonalcoholic steatohepatitis, according to a press…
More Headlines »

Cirrhosis and Hepatic Encephalopathy – Managing Their Consequences and Complications

This activity is supported by an educational grant from Salix Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC.

Cirrhosis, or advanced fibrosis of the liver, can lead to serious health sequelae or death. However, substantial…
More »
GI Bookshelf

Question 28: I Have A Patient With Biliary-Type Pain, But No Other Evidence Of Bile Duct Disease (Normal Diameter Duct On Ultrasound, Normal Liver Function Tests). How Should Such A Patient Be Managed?

From Curbside Consultation in Endoscopy: 49 Clinical Questions, Second Edition
More »
Meeting News

VIDEO: DAAs for youngest pediatric patients with HCV on the horizon

April 29, 2019
More »